Consistent with these findings, a study reported that CBFB and Runx2 play essential roles in the expression of genes that mediate the ability of metastatic breast cancer cells to control osteoclast and osteoblast activities [20]. The gene discussed is RUNX2; the disease is breast carcinoma.